# MZF1

## Overview
MZF1 (myeloid zinc finger 1) is a gene that encodes a transcription factor protein involved in the regulation of gene expression, particularly in hematopoiesis and myeloid cell differentiation. The MZF1 protein is characterized by its zinc finger domains, which facilitate DNA binding, and a SCAN domain that enables protein-protein interactions. These structural features categorize MZF1 as a zinc finger transcription factor. It plays a pivotal role in the transcriptional regulation of genes essential for granulopoiesis, influencing cell cycle progression and differentiation. MZF1's activity is crucial for normal hematopoietic development, and its dysregulation is associated with various pathological conditions, including leukemogenesis and cancer. The gene's expression and function are modulated by post-translational modifications and interactions with other proteins, highlighting its complex regulatory mechanisms (Bavisotto1991Antisense; Noll2008Heterodimer; Morris1994Characterization).

## Structure
The myeloid zinc finger 1 (MZF1) protein is a transcription factor characterized by its zinc finger domains, which are crucial for DNA binding. MZF1 contains 13 C2H2-type zinc fingers arranged in two distinct domains. The first domain includes zinc fingers 1 to 4, while the second domain comprises zinc fingers 5 to 13, separated by a glycine- and proline-rich sequence (Morris1994Characterization). Both domains bind DNA, recognizing consensus sequences with a G-rich core (Morris1994Characterization).

MZF1 also features a SCAN domain, a conserved motif found in many zinc finger proteins, which facilitates protein-protein interactions. The SCAN domain of MZF1 forms a domain-swapped dimer, with each monomer consisting of five alpha helices. This dimerization is essential for MZF1's association with promyelocytic leukemia nuclear bodies (PML-NBs) (Noll2008Heterodimer; Peterson2006Structure). The SCAN domain's dimer interface is primarily composed of residues from helix 3, with additional interactions involving the α1-α2 loop and helix 2 (Peterson2006Structure).

Post-translational modifications of MZF1 include SUMOylation, which involves small ubiquitin-related modifiers and affects its localization and function (Noll2008Heterodimer). MZF1 may also exist in different isoforms due to alternative splicing, potentially altering its functional properties.

## Function
MZF1 (myeloid zinc finger 1) is a transcription factor that plays a crucial role in hematopoiesis, particularly in the differentiation and development of myeloid cells. It is primarily expressed in myeloid progenitor cells and is involved in regulating the transcription of genes essential for granulopoiesis, the process of forming granulocytes, a type of white blood cell (Morris1994Characterization; Bavisotto1991Antisense). MZF1 contains 13 zinc finger domains, which allow it to bind to specific DNA sequences and regulate gene expression (Hromas1991A).

In healthy human cells, MZF1 is active in the nucleus, where it modulates the expression of genes involved in cell cycle progression and differentiation. It acts as a transcriptional regulator by binding to the promoters of hematopoiesis-specific genes, such as CD34 and c-myb, influencing their activity and thereby affecting cell proliferation and differentiation (Perrotti1995Overexpression; Morris1994Characterization). MZF1's expression is upregulated during granulocytic differentiation, indicating its role in the regulation of transcription during myeloid differentiation (Morris1994Characterization).

The protein's function is critical for maintaining normal hematopoietic development, and its dysregulation can lead to impaired blood cell formation and potentially contribute to leukemogenesis (Morris1994Characterization).

## Clinical Significance
Mutations and alterations in the expression of the MZF1 gene have significant clinical implications in various cancers. In gastric cancer, MZF1 acts as a tumor suppressor, and its epigenetic silencing is associated with poor prognosis. The interaction of MZF1 with metallothionein 2a (MT2A) in the MT2A-NF-κB pathway is crucial for mediating anti-tumor effects, and its downregulation correlates with advanced cancer stages and reduced survival times in patients (Lin2019Transcription).

In breast cancer, MZF1 is involved in promoting cancer cell invasion by upregulating genes like N-cadherin and AXL, which contribute to epithelial-mesenchymal transition (Brix2020Zinc). MZF1's transcriptional activity is enhanced by phosphorylation, particularly at serine 27, which is linked to ErbB2 status in breast tumors, promoting cancer cell invasion (Brix2020Zinc).

MZF1 is also implicated in other cancers, such as lung, bladder, and uterine cancers, where its expression is significantly amplified, suggesting its role as an oncogenic factor (Nygaard2016The). The gene's interaction with SCAN domain proteins and its regulation through post-translational modifications further influence its role in cancer progression (Brix2020Zinc).

## Interactions
MZF1 (myeloid zinc finger 1) is a transcription factor that participates in various protein-protein and protein-DNA interactions. It contains a SCAN domain, which facilitates dimerization with other zinc finger proteins, such as ZNF24, ZNF202, and ZNF174. These interactions have been demonstrated through GST-pulldown assays and confirmed by NMR spectroscopy, indicating the formation of stable heterodimers, particularly with ZNF24 (Noll2008Heterodimer).

MZF1 is also involved in the regulation of gene expression by binding to specific DNA sequences. It has two independent DNA-binding domains, each recognizing distinct consensus sequences with a common G-rich core. The first domain binds to the sequence 5'-AGTGGGGA-3', while the second domain binds to 5'-CCGnGAGGGGGAA-3'. These interactions are crucial for MZF1's role in gene regulation during hematopoiesis (Morris1994Characterization).

In addition to its DNA-binding capabilities, MZF1 interacts with the Yes-Associated Protein 1 (YAP1) enhancer in cancer cells, particularly osteosarcoma, in cooperation with GA Binding Protein (GABP). This interaction is significant for the regulation of YAP1 expression, as demonstrated by Electrophoretic Mobility Shift Assay (EMSA) and Chromatin Immunoprecipitation (ChIP) assays (Verma2017Myeloid).


## References


[1. (Verma2017Myeloid) Narendra Kumar Verma, Abhilash Gadi, Giulia Maurizi, Upal Basu Roy, Alka Mansukhani, and Claudio Basilico. Myeloid zinc finger 1 and ga binding protein co-operate with sox2 in regulating the expression of yes-associated protein 1 in cancer cells. Stem Cells, 35(12):2340–2350, September 2017. URL: http://dx.doi.org/10.1002/stem.2705, doi:10.1002/stem.2705. This article has 13 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1002/stem.2705)

[2. (Perrotti1995Overexpression) Danilo Perrotti, Paola Melotti, Tomasz Skorski, Ida Casella, Cesare Peschle, and Bruno Calabretta. Overexpression of the zinc finger protein mzf1 inhibits hematopoietic development from embryonic stem cells: correlation with negative regulation of cd34 and c-myb promoter activity. Molecular and Cellular Biology, 15(11):6075–6087, November 1995. URL: http://dx.doi.org/10.1128/MCB.15.11.6075, doi:10.1128/mcb.15.11.6075. This article has 141 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/MCB.15.11.6075)

[3. (Lin2019Transcription) Shuye Lin, Xiaoyue Wang, Yuanming Pan, Rongmeng Tian, Bonan Lin, Guosheng Jiang, Keqiang Chen, Yuqi He, Lulu Zhang, Wanli Zhai, Peng Jin, Lang Yang, Guoqiang Li, Yun Wu, Jiang Hu, Wanghua Gong, Zhijie Chang, Jian-qiu Sheng, Youyong Lu, Ji Ming Wang, and Jiaqiang Huang. Transcription factor myeloid zinc-finger 1 suppresses human gastric carcinogenesis by interacting with metallothionein 2a. Clinical Cancer Research, 25(3):1050–1062, February 2019. URL: http://dx.doi.org/10.1158/1078-0432.ccr-18-1281, doi:10.1158/1078-0432.ccr-18-1281. This article has 32 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/1078-0432.ccr-18-1281)

[4. (Brix2020Zinc) Ditte Marie Brix, Knut Kristoffer Bundgaard Clemmensen, and Tuula Kallunki. Zinc finger transcription factor mzf1—a specific regulator of cancer invasion. Cells, 9(1):223, January 2020. URL: http://dx.doi.org/10.3390/cells9010223, doi:10.3390/cells9010223. This article has 32 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells9010223)

[5. (Morris1994Characterization) Jennifer F. Morris, Robert Hromas, and Frank J. Rauscher. Characterization of the dna-binding properties of the myeloid zinc finger protein mzf1: two independent dna-binding domains recognize two dna consensus sequences with a common g-rich core. Molecular and Cellular Biology, 14(3):1786–1795, March 1994. URL: http://dx.doi.org/10.1128/mcb.14.3.1786-1795.1994, doi:10.1128/mcb.14.3.1786-1795.1994. This article has 9 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.14.3.1786-1795.1994)

[6. (Noll2008Heterodimer) LeAnne Noll, Francis C. Peterson, Paulette L. Hayes, Brian F. Volkman, and Tara Sander. Heterodimer formation of the myeloid zinc finger 1 scan domain and association with promyelocytic leukemia nuclear bodies. Leukemia Research, 32(10):1582–1592, October 2008. URL: http://dx.doi.org/10.1016/j.leukres.2008.03.024, doi:10.1016/j.leukres.2008.03.024. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.leukres.2008.03.024)

[7. (Nygaard2016The) Mads Nygaard, Thilde Terkelsen, André Vidas Olsen, Valentina Sora, Juan Salamanca Viloria, Fabio Rizza, Sanne Bergstrand-Poulsen, Miriam Di Marco, Mette Vistesen, Matteo Tiberti, Matteo Lambrughi, Marja Jäättelä, Tuula Kallunki, and Elena Papaleo. The mutational landscape of the oncogenic mzf1 scan domain in cancer. Frontiers in Molecular Biosciences, December 2016. URL: http://dx.doi.org/10.3389/fmolb.2016.00078, doi:10.3389/fmolb.2016.00078. This article has 33 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fmolb.2016.00078)

[8. (Peterson2006Structure) Francis C. Peterson, Paulette L. Hayes, Jeanette K. Waltner, Alicia K. Heisner, Davin R. Jensen, Tara L. Sander, and Brian F. Volkman. Structure of the scan domain from the tumor suppressor protein mzf1. Journal of Molecular Biology, 363(1):137–147, October 2006. URL: http://dx.doi.org/10.1016/J.JMB.2006.07.063, doi:10.1016/j.jmb.2006.07.063. This article has 27 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/J.JMB.2006.07.063)

[9. (Hromas1991A) R. Hromas, S.J. Collins, D. Hickstein, W. Raskind, L.L. Deaven, P. O’Hara, F.S. Hagen, and K. Kaushansky. A retinoic acid-responsive human zinc finger gene, mzf-1, preferentially expressed in myeloid cells. Journal of Biological Chemistry, 266(22):14183–14187, August 1991. URL: http://dx.doi.org/10.1016/s0021-9258(18)98664-3, doi:10.1016/s0021-9258(18)98664-3. This article has 134 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/s0021-9258(18)98664-3)

[10. (Bavisotto1991Antisense) L Bavisotto, K Kaushansky, N Lin, and R Hromas. Antisense oligonucleotides from the stage-specific myeloid zinc finger gene mzf-1 inhibit granulopoiesis in vitro. The Journal of experimental medicine, 174(5):1097–1101, November 1991. URL: http://dx.doi.org/10.1084/jem.174.5.1097, doi:10.1084/jem.174.5.1097. This article has 58 citations.](https://doi.org/10.1084/jem.174.5.1097)